If you are:
Only When Necessary:
FDB Contraindicated or Not Recommended: FETAL DEATH/MORBIDITY W/USE IN 2ND & 3RD TRIMESTER, STOP WHEN PREGNANCY DETECTED
Precaution: EXCRETED IN RATS; INSUFFICIENT HUMAN DATA AVAILABLE; MFR DOES NOT REC
No Known Risk: LIMITED DATA SUGGEST INFANT LEVELS ARE LOW WITH NO RESULTING ADVERSE EFFECTS
An adult over 60:
management or monitoring precaution: Cardiovascular-Elderly are more sensitive to blood pressure lowering effects and may have lower drug clearance. Start at lower doses and titrate upward more slowly. Peripheral edema may be common. Gastrointestinal-may cause or worsen pre-existing constipation.
management or monitoring precaution: General-Monitor for increased serum creatinine or hyperkalemia. Cardiovascular-Monitor for hypotension.
Giving Tarka to a child under 12:
management or monitoring precaution: Safety and efficacy not established.
management or monitoring precaution: Safety and efficacy of oral dose form not established. Dosing guidelines available.